Drug Shortage Report for SANDOZ DILTIAZEM CD

Last updated on 2021-10-14 History
Report ID 59502
Drug Identification Number 02243338
Brand name SANDOZ DILTIAZEM CD
Common or Proper name DILTIAZEM
Company Name SANDOZ CANADA INCORPORATED
Market Status CANCELLED POST MARKET
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 120MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 100S
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-06-08
Estimated end date Unknown
Actual end date 2021-10-14
Shortage status Resolved
Updated date 2021-10-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v40 2021-10-14 French Compare
v39 2021-10-14 English Compare
v38 2020-04-15 French Compare
v37 2020-04-15 English Compare
v36 2020-04-06 French Compare
v35 2020-04-06 English Compare
v34 2020-03-30 French Compare
v33 2020-03-30 English Compare
v32 2020-02-15 French Compare
v31 2020-02-15 English Compare
v30 2020-01-08 French Compare
v29 2020-01-08 English Compare
v28 2019-12-10 French Compare
v27 2019-12-10 English Compare
v26 2019-10-15 French Compare
v25 2019-10-15 English Compare
v24 2019-09-10 French Compare
v23 2019-09-10 English Compare
v22 2019-08-14 French Compare
v21 2019-08-14 English Compare

Showing 1 to 20 of 40